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Abstract. Actin-based gels were prepared from clari- 
fied high-salt extracts of human platdets by dialysis 
against physiological salt buffers. The gel was partially 
solubilized with 0.3 M KC1. Mice were immunized 
with the 0.3 M KC1 extract of the actin gel, and hybri- 
domas were produced by fusion of spleen cells with 
myeloma cells. Three hybridomas were generated that 
secrete antibodies against an 80-kD protein. These 
monoclonal antibodies stained stress fibers in cultured 
cells and cross-reacted with proteins in several tissue 
types, including smooth muscle. The cross-reacting 
protein in chicken gizzard smooth muscle had an ap- 
parent molecular weight of 140,000  and was demon- 
strated to be caldesmon, a calmodulin and actin-bind- 
ing protein (Sobue, K., Y. Muramoto, M. Fujita, and 
S. Kakiuchi, Proc. Natl. Acad. Sci.  USA,  78:5652- 
5655). No proteins of molecular weight greater than 
80 kD were detectable in platelets by immunoblotting 
using the monoclonal antibodies. The 80-kD protein 
is heat stable and was purified using modifications of 
the procedure reported by Bretscher for the rapid pu- 
rification of smooth muscle caldesmon (Bretscher, A., 
1985, J. Biol. Chem., 259:12873-12880).  The 80-kD 
protein bound to calmodulin-Sepharose in a Ca  ++- 
dependent manner and sedimented with actin fila- 
ments, but did not greatly increase the viscosity of F- 
actin solutions. The actin-binding activity was inhib- 
ited by calmodulin in the presence of calcium. Except 
for the molecular weight difference, the 80-kD platelet 
protein appears functionally similar to 140-kD 
smooth muscle caldesmon. We propose that the 80- 
kD protein is platelet caldesmon. 
C 
A  LDESMON is a calmodulin- and actin-binding protein 
originally identified  in  and  purified  from  chicken 
gizzard smooth  muscle  (20). The  purified  gizzard 
protein contains two peptides of 138,000 and  140,000 tool 
wt. There is conflicting evidence as to whether the protein is 
a dimer. The actin-binding activity is regulated by calmodulin. 
In the presence of micromolar calcium, calcium-calmodulin 
forms a complex with caldesmon. This complex binds poorly 
to actin filaments. Reducing the calcium level below l #M 
results in the release of calmodulin  and restores the actin- 
binding  activity of caldesmon (4,  20). Purified caldesmon 
inhibits the "superprecipitation" of  actin and myosin ( 17, 21 ) 
and  also inhibits  the  actin-activated  ATPase activity  of 
smooth muscle myosin. This inhibitory activity of  caldesmon 
may depend upon its phosphorylation state (17). Kakiuchi 
and co-workers  have developed a model in which they propose 
that calmodulin and caldesmon act as a regulatory system for 
the interaction of actin and myosin (20, 21). Caldesmon is 
also reported to be a potent actin filament cross-linker, and 
at high molar ratios will organize actin filaments into bundles 
(3). Caldesmon is not specific to smooth muscle, since anti- 
bodies raised against chicken gizzard caldesmon detect cross- 
reacting peptides in immunoblots of nonmuscle cells, which 
include cultured cells and platelets (4,  12,  18,  19). Some of 
the peptides detected in these nonmuscle tissues have molec- 
ular  weights lower than  140,000. In  immunofluorescence 
studies, anti-ealdesmon polyclonal antibodies localize caldes- 
mon on the stress fibers of  cultured cells (4, 19). 
We have been interested in the structure and regulation of 
the actin cytoskeleton in human platelets and have studied 
the gelation of actin in platelet extracts. These gels contain 
actin,  myosin,  alpha-actinin,  and  several minor proteins. 
Monoclonal antibodies have been raised to some of  the minor 
components  of these gels. We report  particularly on three 
hybridomas that have been generated which produce mono- 
clonal antibodies that recognize a previously unidentified 80- 
kD platelet protein. These antibodies cross-react  with material 
from sources other than platelets and with purified chicken 
gizzard caldesmon. Immunofluorescence studies on cultured 
cells localize the 80-kD protein in stress fibers. The platelet 
protein has been purified and shown to have actin-binding 
activity that is regulated by calmodulin. It appears to be a 
nonmuscle  caldesmon  of a  size smaller than the  smooth 
muscle protein. 
Materials and Methods 
Platelet Actin Gel Production and Fractionation 
Fresh or outdated platelets were obtained from the local blood center and were 
rotated at 18°C until used. Platelet high salt extracts, 0.6 M KC1, were prepared 
using a method similar to that reported previously (5).  In some experiments, 
to ensure activation, platelets were treated wtih  10  ~M  of Ca  2÷ ionophore, 
© The Rockefeller University Press, 0021-9525/86/05/1748/10 $1.00 
The Journal of Cell Biology, Volume 102, May 1986 1748-1757  1748 A23187, before sonication. The high salt platelet extract was dialyzed overnight 
against  100 vol of 100 mM KC1, l0 mM imidazole-HCl,  l mM EGTA,  l mM 
NAN3, pH 7.5, at 4"C. An actin gel formed during dialysis and was collected by 
centrifugation at 8,000 g, then washed three times with the dialysis buffer. The 
washed gel was extracted twice for 15 rain with 10 vol of 2 mM Tris-HCl, 0.2 
mM CaCI2, 0.1  mM NAN3, pH 7.5. This removed  most of the alpha-actinin 
and some actin (10). The alpha-actinin-depleted  gel was recovered by eentrif- 
ugation and extracted twice for 15 rain with 5 vol of 0.3 M KCI, 20 mM Tris- 
HCI, 2 mM EGTA,  1 mM NAN3, pH 7.5. The supernatants were recovered by 
centrifugation and the gel residue, largely actomyosin, was discarded. 
Monoclonal Antibody Production 
Monoclonal  antibodies  were produced  using the  methods reported  for the 
production  of monoclonal  antibodies to platelet gelsolin (11 ). The mice were 
immunized with ~20 ug of 0.3 M KO extract protein per injection. After five 
injections, a high titer response, positive by immunoblotting at greater than a 
1:2,000 dilution,  was detected against several proteins  from the platelet con- 
tractile gel. 
The animal was killed, the spleen was removed, and splenoeytes were fused 
with  A653 myeloma cells as  described  previously  (11). Hybridomas  were 
screened  by  ELISA  assay and  by immunoblotting against  the  0.3  M  KCI 
supernatant.  ELISA and immunobiot positive hybridomas were screened fur- 
ther by immunofluorescence  methods described  below. Cloned  hybridomas 
were re-tested by all three methods. Larger quantities of  monoclonal antibodies 
were obtained by injection of 108 hybridoma cells into the peritoneal cavity of 
pristane-primed  mice and subsequent  collection of  ascites fluid. One monoclo- 
nat, 23H2, was adapted to and grown in defined media to obtain antibody free 
of contaminating  mouse proteins  (11 ). The 23H2 antibody was used in most 
of the experiments reported here, but the results obtained with all of the anti- 
80-kD antibodies were similar. We have not yet localized the epitope(s). 
Immunoblotting Procedure 
Immunoblots were performed by a modification  of the method of Towbin et 
al. (25). Briefly, proteins separated by electrophoresis in 8 or 10% SDS poly- 
acrylamide gels were electrophoretically transferred to nitrocellulose sheets. The 
nitrocellulose sheets were blocked for 24 h in Dnlbeeco's  phosphate-buffered 
saline (PBS) without Ca  ++ and Mg  ÷+, that contained 5% calf serum, 1% gelatin, 
1% bovine serum albumin (BSA), and  10 mM NaNj.  The sheets were then 
blotted  with the first antibody,  either  culture  supematants or d/luted  aseites 
fluid.  After  washing  and  incubation  with  peroxidase-conjugated  goat  anti- 
mouse IgG (CooperBiomedical,  Inc.,  Malvern,  PA), the immunoblots were 
extensively washed with PBS that contained 0.1% Triton X-100 and developed 
with 0.5% 4-chloro-l-naphthol  and 0.02% H202. Occasionally immunoblots 
were done using polyclonal antibodies made in rabbits; peroxidase-conjugated 
goat anti-rabbit lgG (CooperBiomedical, Inc.) was used in the second incuba- 
tion step. 
Cell Culture 
Cell lines were maintained  in Dulbecco's modified Eagle's medium that con- 
tained  10%  fetal calf  serum  and  penicillin/streptomycin.  Media  used  for 
hybridomas  contained  0.1  mM  2-mercaptoethanol  and  10%  hybridoma- 
screened fetal calf serum.  Hybridomas  were grown in air that contained  5% 
CO2; other lines were kept in 7% CO2. Swiss 3T3 cells were obtained from the 
American Type Culture Collection; human foreskin fibroblasts were a gift from 
Dr. David Via (Baylor College of Medicine), Bovine aorta smooth muscle cells 
were a gift from Dr. Suzanne Eskin (Baylor College of Medicine). For immu- 
nofluorescence studies, cells were grown to ~50%  confluency on glass cover- 
slips. 
Indirect Immunofluorescence 
lmmunofluorescence  staining of cells on coverslips was done using a method 
similar to that published by Carton et ai. (6). Cells on coverslips were rinsed in 
Dulbecco's PBS without Ca  ++ and Mg  ++, then fixed in 3% formaldehyde,  1% 
dimethyl  sulfoxide in this PBS, for 20 rain at room temperature.  Coverslips 
were rinsed in PBS, then extracted and permeabilized in acetone at -20"C for 
6-7  min.  Coverslips were  rinsed  again  in  PBS and  incubated  in the  first 
antibody, usually hybridoma culture supernatant,  at 37"C for 1 h. After rinsing 
in PBS, the coverslips were incubated  in fluorescently tagged goat anti-mouse 
IgG (CooperBiomedical, Inc.). Some experiments included labeling with fluo- 
rescein-tagged phalloidin  (a gift of Dr.  T.  Wieland,  Max-Planck-Institut  ffir 
Medizinische,  Heidelberg,  West Germany).  This was either  included  in the 
second antibody  incubation  or a third incubation  of 30 min was performed 
with phalloidin at a concentration  of 10 #g/ml. Tetramethylrhodamine  isothic~ 
cyanate--conjugated second antibody was used in the double-label studies. The 
coverslips were mounted and examined as described (6). Final magnifications 
are as indicated. 
lmmunofluorescence  staining of platelets was done on platelets spread on 
glass coverslips. Platelets were obtained  as platelet-rich  plasma, diluted  with 
Dulbeeco's PBS, then allowed to spread on glass coverslips for 1-15 rain. The 
platelets were then processed for indirect  immunofluorescence  as described 
previously (6). Use of polylysine-coated coverslips did not affect the degree of 
attachment  and spreading. Calf serum at a concentration  of 10% was included 
in the antibody staining reagents to minimize background. 
Protein Purification 
Actin was isolated from rabbit skeletal muscle by the method of Spudich and 
Watt (24) and was further purified by gel-filtration on Sephadex G-150 (14). 
Chicken gizzard caldesmon  was purified  using the method described  by 
Bretscher (3). The platelet 80-kD protein was purified using a modification of 
this procedure. Platelets were obtained from the local blood center and washed 
as described previously  (5). Washed  platelets were resuspended  in 6  vol of 
extraction buffer, 0.3 M KCI, 5 mM EGTA, 2 mM MgCl2, 0.5 mM diisopro- 
pylfluorophosphate,  50  mM imidazole-HC1, pH 6.9, then sonieated  in 30-s 
bursts, with cooling on ice in between, for a total of 6 rain.  The lysate was 
heated, with constant stirring, in a boiling water bath until the temperature  of 
the lysate reached 90*¢2, then was held at this temperature  for 5 rain.  After 
cooling on ice, the lysate was clarified at 50,000 g for 30 min at 4"C. The heat- 
soluble  extract  was then  fractionated  with  (Nl-h~zSO4. The  30-50%  pellet 
contained the 80-kD protein, as determined  by gel eleetropboresis and immu- 
noblot.  This pellet was resuspended in 2 ml of 30 mM NaCI,  1 mM EGTA, 
0.1 mM dithiothreitol  (DTT), t 10 mM imidazole-HC1, 0.1 mM NAN3, pH 7.0 
and dialyzed against the same buffer. This material  was loaded onto a 5 ml 
DEAE-Sephacel column equilibrated with the above buffer and eluted with a 
30-500 mM NaC! gradient. The protein content was determined, and fractions 
were analyzed by 8% SDS polyacrylamide gel electrophoresis. Fractions that 
contained  the 80-kD protein  were pooled and dialyzed against  100 mM KC1, 
0.1 mM EGTA, 0.1 mM DTT, 0.1 mM NAN,, 10 mM Tris-HCI, pH 7.5. The 
80-kD protein  could also be purified from the 30-50%  (NI-LhSO4 pellet by 
affinity chromatography  on calmodulin-Sepharose  (Pharmaeia  Fine Chemi- 
cals, Piseataway, NJ). The 30-50%  pellet was resnspended in  100 mM KCI, 
0.1 mM EGTA, 0. I mM DTT, 0. I mM NAN3, 10 mM Tris HCI, pH 7.5. Cacl2 
was added to the dialyzed material to a concentration  of 0.2 mM and applied 
to a 5 ml calmodulin-Sepharose  column.  The column was washed with 200 
mM KC1, 0.2 mM CaC12, 0.1 mM DTT, 0.1 mM NAN3, 10 mM Tris-HCl, pH 
7.5  and eluted  with  1 mM EGTA  in the same buffer.  The fractions  were 
analyzed on 10% SDS polyacrylamide gel electrophoresis. 
Low-shear Viscometry 
Falling-ball viscometry, a low-shear viscometric method,  was done following 
the  method  of MacI_gan-Fletcher and  Pollard  (15). The  140- and  80-kD 
caldesmons used in the assay were dialyzed against polymerization buffer (100 
mM KCi, 5 mM NaPipes,  1 mM ATP,  1 mM Mgcl2, pH 7.0), then mixed 
with F-actin at a final actin concentration  of 12 I~M. The samples were drawn 
up into 100-~1 capillary tubes and incubated at room temperature for 1 h. The 
apparent viscosity was measured by timing a 0.64-ram stainless steel ball falling 
2  cm through the  sample  at  an  80*  inclination.  The apparent viscosity is 
expressed as the ratio of the viscosity of  the sample to that of the actin control. 
Sedimentation 
Sedimentation  assays were  used  to  examine  the  interaction  of actin  with 
caldesmon  and  the  80-kD  protein.  Proteins  in  polymerization  buffer  were 
mixed and incubated in centrifuge tubes at room temperature for 1 h. The final 
concentrations  of protein  were as follows: actin,  12 ~M; 80-kD protein,  cal- 
modulin, and 140-kD caldesmon, as given in figure legends. The samples were 
then centrifuged  in an airfuge at  30  psi  for 30  rain at room temperature, 
conditions  that sediment  F-actin.  After  centrifugation,  the supernatant  was 
carefully aspirated off  the pellet, and the pellet was resuspended in a volume of 
sample buffer equal to the original volume of the sample. Both supernatants 
and pellets were analyzed on 8%  SDS polyacrylamide  gels. The amount of 
caldesmon  protein  present  in the pellet and supernatant  was quantitated  by 
densitometric scanning of the Coomassie Blue-stained gels. 
1. Abbreviations used in this paper: DTT, dithiothreitol; MLCK, myosin light 
chain kinase. 
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SDS polyacrylamide  gel electrnphorcsis  was done according  to Laemmli (13). 
Whole cell and tissue samples were prepared for elcctrophoresis  by homogeni- 
zation in boiling  Laemmli  sample buffer  followed  by heating  to 95"C  for 5 min. 
Protein determinations were done using a modification of the method of 
Bradford (2). 
Results 
Preparation of  Platelet Actin Gels 
Fig.  1 shows the SDS polyacrylamide gel electrophoresis pro- 
files from different steps in the preparation of actin gels from 
platelets.  These gels were formed by dialyzing extracts from 
activated  or  unactivated  platelets  against  physiological salt 
buffers. Unactivated platelet  extracts produced gels with al- 
pha-actinin and actin as the only major components (Fig.  1, 
lane 3).  If platelets were activated before sonication, the gels 
also contained myosin as a  major component, along with a 
140-kD protein  (Fig.  1,  lane  6),  a  proteolytic fragment  of 
myosin, identified using anti-myosin monoclonal antibodies 
(data not shown). The myosin-containing gels from activated 
platelets contracted during gelation. The smooth, translucent 
appearance  of this  contractile  gel  was  different  from  the 
flocculent appearance of the unactivated gels.  Both types of 
gel also contained several minor protein components. 
Specific components of  the contractile gel could be removed 
by extraction of the gel with different salts.  A low-salt buffer 
that contained Ca  ++ was used to extract most of the alpha- 
actinin  and  some  of the  actin  (Fig.  1,  lane  7).  This  Ca  ++ 
extract was used to purify alpha-actinin and platelet actin as 
previously reported (10). Extraction of the alpha-actinin de- 
pleted  gel  with  0.3  M  KC1  buffer  that  contained  EGTA 
removed most of  the 140-kD myosin fragment, some myosin, 
and a few minor components (Fig.  1, lane 8). The remaining 
gel residue contained actin, some myosin, and several minor 
components. 
Monoclonal Antibody Characterization 
The 0.3 M  KCI/I  mM EGTA extract of the activated, con- 
tractile gel was used to immunize mice.  After 3  mo of im- 
munization,  sera exhibited a  strong response against several 
platelet  proteins  when  used  at a  dilution  of 1:2,000 in im- 
munoblots. Spleen cells were used to prepare hybridomas by 
fusion with A653 myeloma cells.  Antibody-producing hybri- 
domas were screened by ELISA, immunoblot,  and  indirect 
immunofluorescence.  Most  of the  monoclonal  antibodies 
were to either a  260-kD protein,  presumably platelet  actin- 
binding protein,  or to myosin. Three antibodies,  6D2,  8B5, 
and 23H2 recognized an unidentified 80-kD protein (Fig. 2). 
The three anti-80-kD antibodies have given identical results 
on  immunoblots  and  immunofluorescence  staining  experi- 
ments. 
Figure 1. SDS polyacrylamide  gel electrophoresis  of platelets  and 
platelet fractions. Samples from various steps in the preparation  of 
platelet aetin gel extracts were analyzed by 8% SDS polyacrylamide 
gel electrophoresis. Lanes I and 4, whole platelets; lane 2, supernatant 
above unactivated platelet gel; lane 3, unactivated platelet gel; lane 5, 
supernatant above activated platelet contractile gel; lane 6, contractile 
gel; lane 7, Ca  ++ extract of contractile gel; lane 8, 0.3 M KCI/EGTA 
extract  of contractile  gel. The molecular  weights of standards,  in 
kilodaltons,  are shown at right. The standards  used were: phospho- 
rylase b, 94,000; BSA, 68,000; ovalbumin,  43,000; carbonic  anhy- 
drase, 30,000; soybean trypsin inhibitor,  21,000; lysozyme, 14,300. 
Figure 2.  Comparison  of immunoblots performed  with  the  three 
monoclonal antibodies to 80-kD protein. After electrophoresis on 8% 
SDS polyacrylamide  gels, whole platelet  protein  was transferred  to 
nitrocellulose, and immunoblots were done using culture  superna- 
tants  from the three  hybridomas.  Lane 1, Coomassie Blue-stained 
gel; lane 2, 6D2; lane 3, 8B5; lane 4, 23H2. Molecular weights are 
shown in kilodaltons. 
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by Indirect Immunofluorescence 
All of the hybridomas were screened by indirect immunoflu- 
orescence using culture  supernatant  in  the  first incubation 
step. Positive clones were selected for expansion. The anti-80- 
kD antibodies stained the stress fibers in human cells (Fig. 
3 A) and cross-reacted with non-human cells, including mouse 
3T3 cells (Fig. 3B) and bovine smooth muscle cells (Fig. 3 C). 
The antibodies stained platelets, but little detail was visible 
(data not shown). The stress fibers were brightly stained in all 
instances, and the staining pattern appeared somewhat peri- 
odic, similar to that seen with anti-myosin antibodies (Fig. 
3D).  Double-label  studies,  not  shown,  indicated  that  the 
localization of the 80-kD protein in the cell was very similar 
to  that  of actin.  The  staining  patterns  seen with the  three 
different  anti-80-kD  antibodies  were  indistinguishable;  ex- 
amples of all three are shown in Fig. 3. 
Identification and Initial Characterization of the 
80-kD Protein 
Immunoblot analysis was done on samples from the various 
steps in the preparation of the platelet contractile gel. The 80- 
kD protein was present in whole platelets, in clarified platelet 
extract, and was enriched in the contractile gel (Fig.  4, lanes 
I, 2, and 4). In some preparations two closely spaced bands 
were resolved. The 80-kD protein was not present in low ionic 
strength-Ca  ++ extracts of the gel (Fig.  4, lane 5), presumably 
because calmodulin was not present, but was removed by the 
0.3 M KC1-EGTA extraction step (Fig. 4, lane 6). 
To examine the cross-reactivity and tissue distribution of 
the 80-kD protein, rat and mouse tissue samples and two cell 
lines, one human and one mouse, were tested by immuno- 
blotting. A mixture of all three anti-80-kD monoclonal anti- 
bodies was used in the immunoblots to maximize the detec- 
tion of cross-reacting proteins that were present in aorta, liver, 
spleen,  uterus,  and  both  types of fibroblasts (Fig.  5).  The 
cross-reacting species in  aorta, liver, spleen,  and  fibroblasts 
had a  molecular weight of ~80,000,  similar to the  platelet 
peptide (Fig. 5, lanes 7-10). The smooth muscle samples (Fig. 
5,  lanes 3,  4,  5,  and 6) contained two sizes  of peptides; the 
molecular weight  of the  major one  was  140,000,  and  the 
minor one was 80,000. Uterus samples from mouse and rat 
contained both peptides. Chicken gizzard smooth muscle also 
contained a  cross-reacting  140-kD peptide (Fig.  5,  lane 5). 
The stained gel of the whole tissue contained a  prominent 
band at 140 kD (Fig. 6, lane 1). All three anti-80-kD antibod- 
ies cross-reacted with  the  chicken  gizzard protein with  ap- 
proximately the same intensity. 
At  least  three  proteins  of ~140,000  mol  wt  have  been 
purified from chicken gizzard; vinculin (8,  9),  myosin light 
chain kinase (MLCK) (1,  7), and caldesmon (3, 20).  Immu- 
noblots were done with chicken gizzard protein using anti- 
bodies  to  vinculin  and  MLCK  to  determine  if they were 
recognized by the anti-80-kD antibody. Anti-smooth muscle 
vinculin was the gift of Dr. Joann Otto (Purdue University, 
West  Lafayette,  IN),  and  anti-MLCK  was  the  gift  of Dr. 
Vincent Guerriero (Baylor College of Medicine). The results, 
shown in Fig. 6, demonstrate that vinculin and MLCK are of 
lower  molecular  weights  than  the  140,000-mol-wt  peptide 
recognized by the anti-80-kD antibody. 
Purification of Gizzard 140-kD Caldesmon and the 
Platelet 80-kD Protein 
140-kD caldesmon was purified according to the published 
procedures of Bretscher (3). The result is shown in Fig. 7, lane 
8. All three anti-80-kD antibodies react strongly with purified 
gizzard caldesmon (see Fig. 7, lanes 8 and 9). The platelet 80- 
kD  protein was purified  using a  modification of the  same 
Figure 3. Immunofluoreseence stain- 
ing of cultured cells using anti-80-kD 
monoclonal antibodies. Various cell 
lines were grown on glass coverslips 
and  processed for  immunofluores- 
cence as described in Materials and 
Methods. Fluorescein isothiocyanate- 
conjugated goat anti-mouse IgG was 
used as the second antibody. (A) Anti- 
80-kD, 23H2, staining of  human fore- 
skin fibroblasts; (B) anti-80-kD stain- 
ing of mouse 3T3 cells; (C) anti-80- 
kD staining of  cultured bovine smooth 
muscle cells with 8B5; (D) high mag- 
nification of stress fibers from human 
foreskin fibroblasts stained with anti- 
80-kD antibody 6D2. The scale bar in 
each panel equals 10 ~m. 
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from various stages in the preparation of contractile gel extracts were 
separated by electrophoresis on duplicate 8%  SDS polyacrylamide 
gels. One of the gels was stained with Coomassie Blue (A) and the 
other  was  transferred  to  nitrocellulose and  immunoblotted  with 
monoclonal antibody 23H2  (B).  Lane  1,  whole platelets;  lane 2, 
clarified platelet lysate; lane 3, superuatant over the contractile gel; 
lane 4, contrac~e gel; lane 5, Ca  ++ extract of the contractile gel; lane 
6, 0.3 M KCI/EGTA extract of  the contractile gel; lane 7, actomyosin 
residue. Molecular weights are shown in ldlodaltons at right. 
caldesmon  isolation procedure  (3).  The  heat-stable protein 
fraction of lysed platelets contained an  80-kD protein as a 
major cross-reacting component (Fig. 7 B, lane 4); little cross- 
Figure 5. Distribution of 80-kD protein and cross-reacting peptides 
in cells and tissues. Rat tissue samples, cultured ceils, and chicken 
~77ard homogenate were separated by electxophoresis on duplicate 
10% SDS polyacrylamide  gels. One gel was stained with Coomassie 
Blue (.4), and one was transferred to nitrocellulose  and immunoblot- 
ted with a mixture of the three anti-80-kD antibodies (B). Lane I, 
platelet lysate; lane 2, rat aorta; lane 3, mouse aorta; lane 4, mouse 
uterus; lane 5, chicken gizzard; lane 6, rat uterus; lane 7, rat spleen; 
lane 8, rat liver, lane 9, WI38 ceil lysate; lane 10, 3T3  mouse cell 
lysate;  lane I1,  whole platelet lysate (control).  Large arrowheads, 
-140,000 tool wt; small arrowheads,  ~80,000 tool wt. 
reacting 80-kD protein was found with the heat-precipitated 
material (Fig. 7 B, lane 3). The major component of the heat- 
stable fraction was a 33-36-kD protein with the characteristics 
of platelet tropomyosin (Fig. 7A, lane 4). The 80-kD protein 
precipitated with 30-50%  (NI-L)2SO4 (Fig. 7A, lane 6) along 
with major unidentified componentS with molecular weights 
of 72,000 and 62,000 that showed no cross-reactivity. 
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weight  than vinculin  or MLCK. Immunoblots were performed on 
nitrocellulose  transfers of whole gizzard homogenate. 8% SDS poly- 
acrylamide gels were used.  Lane t, Coomassie Blue-stained gel of 
whole gizzard; lane 2, immunoblot using anti-80-kD antibody 23H2; 
lane 3, immunoblot using anti-platelet vinculin; lane 4, immunoblot 
using  anti-gizzard vinculin;  lane 5,  immunoblot using  both 23H2 
and  anti-platelet  vinculin;  lane  6,  immunoblot with  anti-MLCK. 
Molecular weights are shown in kilodaltons at left. 
The 80-kD protein elutes from DEAE-Sephacel at 150-200 
mM NaCI, approximately in fractions 43-50, at -95% purity 
(Fig.  8  and inset).  The protein  could be purified initially or 
purified further by affinity chromatography on calmodulin- 
Sepharose. Pooled DEAE fractions, or alternatively the resus- 
pended  30-50%  (NH4)2SO+  pellet, were dialyzed against 0.1 
M  NaCI, 20 mM Tris-HCl, 0.1  mM DTT, 0. I  mM  EGTA, 
pH  7.5.  CaCI2 was  added  to  0.2  mM  and  the  sample  was 
loaded  onto calmodulin-Sepharose  equilibrated  with 0.1  M 
NaCI, 20 mM Tris-HCl, 0.1  mM DTT, 0.2 mM CaCI2. After 
washing with 0.2 M  NaCI in the same buffer, bound protein 
was eluted with 0.2 M  NaCI, 20 mM Tris-HCl, 0.1 mM DTT, 
1 mM EGTA. Fig. 9 shows an elution profile for a purification 
from the entire heat-stable extract.  Contaminants  and some 
of the  80-kD  protein  are etuted  with  0.2  M  NaCI, but  the 
majority  of the  80-kD  protein  is  eluted  with  EGTA.  The 
purified protein gives two bands, visible at low protein loads, 
on  SDS  gels  in  approximately  equimolar  ratio;  both  are 
recognized  by  the  antibody.  The  purified  protein  is  fairly 
stable at 0*C and can be stored for at least 3  wk and retain 
activity. 
Using  polyclonal  antibodies  to  140-kD  caldesmon, 
Bretscher  and  Lynch  (4)  have detected  80-kD  protein(s)  in 
heat  stable  extracts.  In  addition,  Kakiuchi  and  co-workers 
have  reported  the  detection  of  150,000-mol-wt  caldesmon- 
Figure 7. Immunoblot analysis of purification steps for platelet 80- 
kD protein. A heat-stable  protein fraction was prepared from whole 
lysed platelets  and was fractionated with (NI-hhSO+. (A) Coomassie 
Blue-stained gel;  (B) immunoblot using  23H2  antibody of gel in 
panel A. Lane 1, whole platelet  lysate; lane 2, heated whole platelet 
lysate; lane 3, heat-insoluble  pellet; lane 4, heat-stable extract; lane 5, 
30% (NFL)2SO, precipitate;  lane 6, 30-50% (NH4)2SO+ precipitate; 
lane  7, 50-65% (NI-hhSO4 precipitate;  lane 8, purified  caldesmon; 
lane 9, whole gizzard homogenate. Molecular weights are shown in 
kilodaltons  at left. 
like proteins in platelets (12). These results suggest the 80-kD 
protein  may be  a  proteolytic  fragment.  However,  we  have 
been unable to detect cross-reacting platelet proteins of  greater 
than  80,000  mol wt even in  samples of freshly drawn,  gel- 
filtered platelets (16) treated with  several proteolysis inhibi- 
tors.  To  test  directly  for  proteolysis  during  platelet  lysate 
preparation,  purified  140-kD caldesmon  was radioiodinated 
and used  as a  protease target.  12sI-Caldesmon was added to 
the whole platelet suspension (Fig.  10, lane 2) before lysis by 
sonication  or to a  separate sample after sonication  (Fig.  10, 
lane 3). Neither sample showed significant degradation com- 
Dingus  et  al. Human  Platelet Caldesmon  1753 Figure 8. DEAE chromatography of the 30-50% (NH4)2804 fraction  from the heat-stable platelet extract. The 30-50%  (NIq~hSO4 fraction 
from a heat-stable platelet extract was chromatographed  on DEAE-Sephacel. The protein content of  each fraction was determined and analyzed 
by SDS polyacrylamide gel electrophoresis. 80-kD caldesmon elutes at 150-200 mM NaCI in fractions 42-52. The inset at the left is the SDS 
gel of the peak fraction, number 45. 
pared with the starting material  (Fig.  10,  lane  9).  Similarly, 
there was no increase in degradation after further processing 
of the lysates (Fig.  10, lanes 5 and 6).  The size of the endog- 
enous peptide  detected by immunoblotting identically han- 
dled samples that did not contain ~25I-caldesmon  was 80,000 
mol wt (data not shown). We conclude that the 80-kD protein 
is not a breakdown product of  a larger platelet caldesmon and 
that 80,000 mol wt is the native size of platelet caldesmon. 
Comparison  of the Actin-binding Activities of l 40-kD 
Caldesmon  and the 80-kD Protein 
The two purified proteins were used in a  viscosity assay to 
determine if the actin cross-linking activities of 80-kD caldes- 
mon  were  similar  to those  of 140-kD caldesmon.  Samples 
were  prepared  by mixing  either  80-  or  140-kD  caldesmon 
with F-actin at molar ratios ranging from 1:200 to 1:15, then 
incubating for 1 h at 20"C before measuring the viscosity. Fig. 
11 shows the results. Both proteins increased the viscosity of 
Figure 9. Affinity chromatography of 80- 
kD protein on calmodulin-Sepharose.  An 
entire heat-stable extract was chromato- 
graphed on a 5-ml calmodulin-Sepharose 
affinity column.  The column was eluted 
with  the  starting  buffer,  with  200  mM 
KC1 plus  0.2  mM CaCI2 and with  200 
mM KC1 plus  1 mM EGTA. The buffers 
were changed at fractions  9 and  19, re- 
spectively. The protein profile of  the frac- 
tions is shown. The 80-kD protein elutes 
with EGTA. The inset at right is the peak 
fraction, 23, as it appears on a  10% SDS 
gel. 
F-actin, but the gizzard protein had a greater effect than the 
80-kD platelet protein at all concentrations tested. In addition, 
the  actin  cross-linked  with  gizzard  caldesmon  appeared  to 
undergo a marked reduction in viscosity at high molar ratios, 
consistent with the bundling of actin filaments that has been 
reported  for gizzard  caldesmon  (3).  At  the  concentrations 
used,  the  80-kD  caldesmon  did  not  decrease  the  viscosity 
markedly at high molar ratios. 
Centrifugation  experiments  show that both proteins sedi- 
ment with F-actin (Fig.  12, lanes 4 and 8).  At a molar ratio 
of caldesmon to actin of 1:20, both proteins bind to the actin 
filaments, and we detect little caldesmon that is not associated 
with the actin pellet.  Inclusion of Ca  ++ had no effect on the 
binding of either protein to actin filaments.  Neither the 80- 
nor the 140-kD protein sediments alone (Fig.  12, lanes 5 and 
9)  under conditions that  will  pellet  F-actin  alone  (Fig.  12, 
lane 2). 
The binding of 80-kD caldesmon or 140-kD caldesmon to 
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Figure 11. Low-shear viscometry of actin plus 80- or 140-kD caldes- 
mon. 140- or 80-kD caldesmon was mixed with F-actin in polymer- 
izing buffer, incubated, and the viscosity measured. The results are 
expressed as the ratio of the viscosity of the sample to the value for 
the actin control. The circles are the data for 140-kD caldesmon; the 
squares are the data for 80-kD caldesmon. 
Figure 10.  Incubation of radio-iodinated  140-kD caldesmon  with 
platelet lysates. ~25I-labeled  chicken gizzard caldesmon was added to 
duplicate samples of  washed platelets, either before or after sonication 
and then  incubated for  2  h  at  4"C. Samples  were prepared  for 
electrophoresis, run on 8% SDS gels, stained, dried, and autoradi- 
ographed. (.4) Coomassie Blue-stained gel; (B) autoradiogram of gel 
in A. Lane 1, whole platelets (control); lane 2, whole platelet lysate 
with ~25I-caldesmon  added before sonication; lane 3, whole platelet 
lysate with  ~25I-caldesmon  added  after  sonication;  lane 4,  control 
sample after KCI addition and 2-h extraction; lane 5, same sample as 
in lane 2 after KCI addition and extraction; lane 6, same sample as 
in lane 3 after KC1 addition and extraction; lane 7, same sample as 
in lane 1 with 1 #g gizzard caldesmon added; lane 8, gizzard caldes- 
mon; lane 9, unlabeled gizzard caldesmon,  -5 #g, with ~0.1  uCi, 
<50 ng, of ~25I-caldesmon  added. 
F-actin is inhibited  in the presence of calcium and calmodulin 
(Fig. 13). Calmodulin  will inhibit  the binding  of 80-kD protein 
and 140-kD caldesmon to actin filaments, but a large excess 
of calmodulin relative to caldesmon is required for complete 
inhibition of the actin-binding  activity. At a two- to fourfold 
molar ratio of calmodulin to caldesmon, only ~50%  of the 
caldesmon is inhibited from binding to actin filaments and 
Figure 12. Sedimentation analysis of the interaction of 140- and 80- 
kD  caldesmon  with actin.  F-actin was  mixed  with  140  or  80-kD 
caldesmon and incubated for 1 h before centrifugation in an airfuge 
for 30 rain at 30 psi to sediment the actin fdaments. The supernatants 
and pellets were analyzed on 10% SDS polyacrylamide gels. The final 
concentration of protein in the samples was as follows: actin, 12 tzM; 
80- or 140-kD caldesmon, 0.6 ~M. The even-numbered lanes are the 
pellets, and the odd-numbered lanes are the corresponding superna- 
tants. Lanes 1 and 2, actin only; lanes 3 and 4,  actin with  140-kD 
caldesmon; lanes 5 and 6,  140-kD caldesmon alone; lanes 7 and 8, 
actin with 80-kD caldesmon; lanes 9 and 10, 80-kD caldesmon alone. 
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Figure 13. Inhibition of 140- and 80-kD caldesmon binding to actin 
by calmodulin. Samples of 80- and 140-kD caldesmon were mixed 
with actin, in the presence of increasing amounts of calmodulin. All 
samples were run  in  the  presence of calcium. The samples were 
incubated for l h, sedimented, and analyzed on 12% SDS gels. The 
amount of 140- or 80-kD caldesmon remaining in the supematant 
was quantitated by densitometric scanning. The data are plotted as 
the percent of 80-kD caldesmon (I) or 140-kD  caldesmon (0) soluble 
relative to the molar ratio of calmodulin to caldesmon in the sample. 
The actin concentration was 12 uM. The caldesmon 140 or 80 kD 
concentration was 0.5 uM, and the calmodulin concentration varied 
from 1 uM to 8 uM. cam, calmodulin; cdm, caldesmon. 
found in the supernatant over the actin pellet. A ratio of at 
least  8-10  mol  of calmodulin  per  mole  of caldesmon  is 
required for complete inhibition of binding to actin filaments. 
Approximately the  same molar excess is required  by both 
types of caldesmon. 
Discussion 
We have generated hybridomas and produced monoclonal 
antibodies to a previously unknown 80,000-mol-wt cytoskel- 
etal protein from human platelets. This protein is a  minor 
component of the platelet contractile actin gel, but was en- 
riched in the 0.3 M KCI supernatant used to immunize mice 
for hybridoma production. Most of the antibodies produced 
from  this  fusion  were  against  known  platelet  cytoskeletal 
proteins  (Dingus,  J.,  S.  Hwo,  and  J.  Bryan,  unpublished 
results).  Three were against the same 80,000-mol-wt protein. 
These anti-80-kD antibodies cross-reacted with  proteins of 
the same size in nonmuscle tissues, but recognized caldesmon, 
a protein of higher molecular weight in smooth muscle. The 
immunofluorescence localization of the protein on stress fi- 
bers in cultured cells was identical to that reported for caldes- 
mort (4,  19). 
We have purified the 80-kD platelet protein and compared 
its properties to those  of chicken gizzard caldesmon.  Both 
proteins are relatively heat stable and can be purified from 
heat-stable cell extracts. The proteins have similar salt precip- 
itation  and  DEAE binding behavior and both will  bind to 
calmodulin-Sepharose  in  the  presence of calcium and  are 
eluted with EGTA. Additionally, both proteins bind to actin 
filaments and the binding can be inhibited by calmodulin. In 
the  presence of calcium and  calmodulin,  there  is  reduced 
binding of caldesmon and the  80-kD protein to actin fila- 
ments, although complete inhibition  of binding requires  a 
significant excess of calmodulin, which suggests  the affinity 
of caldesmon for actin is significantly greater than  for cal- 
cium-calmodulin. Calcium, or calmodulin in EGTA-contain- 
ing buffers, have no effect on the actin-binding activity of 
either protein. Based on the functional similarities of the two 
proteins, and on the monoclonal antibody cross-reactivity, we 
have concluded that the 80-kD protein is the native form of 
platelet caldesmon. 
The obvious differences between the two caldesmons are 
the molecular weights and the cross-linking activities. We find 
no evidence to suggest  that 80-kD platelet caldesmon is ac- 
tually a breakdown product of a larger caldesmon in platelets. 
Our antibodies do not detect any larger proteins in platelets 
and  140-kD caldesmon, added to the platelet lysates,  is not 
degraded during our handling procedures. It is not clear how 
to reconcile our results with those of Kakiuchi and co-workers 
(12),  who have reported on a  150,000-mol-wt caldesmon in 
platelets. One possibility is that the polyclonal antibodies used 
by these workers were not monospecific. Alternatively, the 
platelet preparations used may have had varying degrees of 
contamination with white blood cells. 
Bretscher (3) has reported that the  140-kD caldesmon is a 
potent actin cross-linking protein that can induce the forma- 
tion  of very large bundles of actin  filaments visible in  the 
phase microscope. This ability of caldesmon to cross-link is 
disputed and has been described as an artifact due to protein 
aggregation (23). We detect little cross-linking activity, defined 
by low shear viscosity, with the  80-kD caldesmon,  but do 
confirm the cross-linking activity of the  140-kD gizzard cal- 
desmon  reported  by  Bretscher.  It  is  conceivable  that  the 
difference in  cross-linking activity between the  two caldes- 
mons is due either to an additional actin-binding site or to a 
site for self-association on the 140-kD protein that is missing 
on the 80-kD caldesmon. This would allow the 140-kD species 
to directly cross-link filaments or to associate then cross-link 
filaments.  Clearly more  detailed  structural  studies  will  be 
required  to  resolve these  questions  and  determine if these 
proteins are derived from separate genes. 
The function of caldesmon in cells is under study. Caldes- 
mort is one of the few actin-binding proteins that  may be 
regulated  directly  by  calmodulin  (4,  20).  Caldesmon  can 
interfere with the interaction of actin and myosin (17,  21). 
Kakiuchi and co-workers have proposed that caldesmon is a 
regulatory protein that controls contraction by a  "flip-flop" 
mechanism (20-22). This model proposes that the interaction 
of actin and myosin is regulated by caldesmon, calmodulin, 
and  Ca  ++.  Under  low  calcium  conditions,  actin  filaments 
would  have caldesmon bound.  When  intracellular calcium 
levels rise above micromolar, the  caldesmon  actin-binding 
activity would be inhibited by the binding of calmodulin to 
caldesmon and allow myosin binding. These conditions also 
allow activation of MLCK and phosphorylation of myosin. 
The effect of 80-kD caldesmon on the actomyosin interaction 
is  unknown,  but  clearly it  could  have  the  same  putative 
regulatory functions as  140-kD caldesmon since it binds to 
The Journal of Cell Biology, Volume  102,  1986  1756 actin filaments and is regulated by calmodulin. One puzzling 
fact for both proteins is the large excess ofcalmodulin required 
for the inhibition of the actin-binding activity. The affinity of 
both  proteins  for  calmodulin  appears  to  be  low  and  the 
binding to  calmodulin  can  be  disrupted  at  fairly  low  salt 
concentrations, unlike prototype calmodulin binding inter- 
actions. The existence of two sizes is interesting but further 
complicates the picture. The low cellular concentration and 
the observation that one form does not effectively cross-link 
filaments suggests a regulatory rather  than a structural role 
for these molecules. 
Received for publication  17 December  1985, and in revised form 9 
January 1986. 
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